Close
Curian® Campy



A rapid, qualitative fluorescent immunoassay for the direct detection of a Campylobacter-specific antigen in stool specimens.

Catalog Number: 760730

Support & Documents

Why Curian Campy?



Curian Campy offers clinicians accurate and timely results to deliver appropriate care for patients infected with campylobacteriosis. The Curian testing platform centers around the innovative Curian analyzer – a compact immunofluorescent instrument that boasts a simple workflow and clean sample handling to provide rapid, definitive results. Coupling Curian Campy with an automated analyzer readout provides a result that can be read without the risk of subjective analysis by the technologist. Curian’s platform flexibility can help standardize testing throughout the health system by bringing testing closer to the patient resulting in improved clinical efficiencies.

  • sample_result_icon
    Standardized workflow – simple 3-step workflow with standardized assay-to-assay sample prep
  • Group 13 Created with Sketch.
    Focused menu – removes subjectivity for enhanced performance from the industry's leading experts in stool handling and testing
  • assay_flexibility_icon
    Total solution – flexible testing options allow the platform to fit any laboratory workload
  • Group 19 Created with Sketch.
    Trusted partner – enables healthcare systems to efficiently maximize resources to deliver standardized care and improve patient outcomes

Definitive answers, confidence in results

Contact Sales

Definitive answers, confidence in results

Contact Sales

Support & Documents

Click below to access our Curian Campy product support materials

Downloadable PDFs

FAQs

Campylobacter infection, or campylobacteriosis, is caused by ingestion of Campylobacter bacteria. It is the most common bacterial cause of diarrheal illness in the United States. People with a Campy infection usually have diarrhea (often bloody), fever, and stomach cramps. The CDC estimates Campylobacter infection affects 1.5 million U.S. residents every year.

Curian Campy is intended to detect C. jejuni, C. coli, C. upsaliensis, and C. lari in human stool from patients with signs and symptoms of gastroenteritis. Over 90% of Campylobacter infections are caused by C. jejuni, about 5% by C. coli and the remainder by other Campylobacter species, such as C. lari or C. upsaliensis.  There is increasing acknowledgment of the clinical importance of Campylobacter species other than C. jejuni and C. coli, due to the recognition of these species as emerging human and animal pathogens.

The test is intended for use with unpreserved fecal specimens or preserved fecal specimens in transport media (Cary-Blair or C&S).

87449

Get In Touch With Us

Contact Us

Welcome to

Please select your country to continue

Continue
CN